DATA GRAPHICS | Deals
Regeneron enters radiotherapy, Gilead buys another biotech, and more: Deals Report
Select biopharma deals, April 7-13
April 13, 2026 10:12 PM UTC
The past seven days saw Gilead continue its deal spree, Regeneron move into radiopharmaceuticals via Telix, and AbbVie access pain candidates from China.
On Monday, Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced a deal with Melbourne-based Telix Pharmaceuticals Ltd. (ASX:TLX; NASDAQ:TLX) to co-develop and co-commercialize four programs, with options to add four more. ...